Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
28.9%
% of CANC's 45 holdings also in BBP
25.0%
% of BBP's 55 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 2.4% | 2.4% | 2.4% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 2.0% | 2.0% |
|
REGENERON PHARMACEUTICALS | 5.6% | 2.0% | 2.0% |
|
MODERNA, INC. | 2.0% | 2.0% | 2.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED ADR | 1.9% | 1.9% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBP
|
MERCK & CO. INC. | 5.6% |
 |
DAIICHI SANKYO CO LTD | 4.0% |
 |
ASTRAZENECA PLC | 3.8% |
 |
NOVARTIS AG | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.6% |
|
ILLUMINA INC | 3.5% |
|
REVOLUTION MEDICINES, INC. | 3.1% |
|
EXACT SCIENCES CORP | 3.1% |
 |
ARGENX SE ADR | 2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | 2.7% |
CANC Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
ADMA BIOLOGICS, INC. | -2.5% |
|
SAREPTA THERAPEUTICS INC | -2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
APELLIS PHARMACEUTICALS, INC. | -2.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | -2.1% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |